BChE-IN-35
BChE-IN-35 (Azo-9) is a BChE inhibitor. BChE-IN-35 has a dynamic cis/trans conformational change, where the cis isomer preferentially binds to BChE. BChE-IN-35 can be used in Alzheimer's disease (AD) research[1].
Product Specifications
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bche-in-35.html
Smiles
CC(C)C1=CC=C(/N=N\C2=CC=C(C(NC3=CC=CC(C(NCC4=CC=CC=C4CN(CC)CC)=O)=C3)=O)C=C2)C=C1
Molecular Formula
C35H39N5O2
Molecular Weight
561.72
References & Citations
[1]Wang L, et al. Optical control of butyrylcholinesterase (BChE) activity via photoswitchable azobenzene for potential treatment of Alzheimer's disease. Bioorg Chem. 2024 Sep 24;153:107845.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472477-500 1x 500 µL
MMP9 (Matrix Metalloproteinase 9) (MMP9/2477), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0747-100 1x 100 µL
CD66 (CEA) (COL-1 + CEA31 + C66/261), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
KN416063 1 Kit
Meprin beta (MEP1B) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 